Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections

Intervirology

Volumn 49, Issue 4, 2006, Pages 249-252

  Henke, Andreas ^a   Rohland, Nadine ^a   Zell, Roland ^a   Wutzler, Peter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Bicistronic plasmid; DNA vaccine; Immunization; Influenza virus; Interleukin 2

Indexed keywords

CYTOKINE; DNA VACCINE; INFLUENZA VACCINE; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; IMMUNOSTIMULATION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A; INTERNAL RIBOSOME ENTRY SITE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; DOGS; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PLASMIDS; VACCINES, DNA; VIRAL PROTEINS;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

EID: 33646688663     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092487     Document Type: Article

References (20)

1. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL: DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 1993;90:11478-11482.
2. Pertmer TM, Eisenbraun MD, McCabe D, Prayaga SK, Fuller DH, Haynes JR: Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 1995;13:1427-1430.
3. Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT: Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol 1997;71:3138-3145.
4. Ray NB, Ewalt LC, Lodmell DL: Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine 1997;15:892-895.
5. Chen SC, Jones DH, Fynan EF, Farrar GH, Clegg JC, Greenberg HB, Herrmann JE: Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol 1998;72:5757-5761.
6. Henke A, Chiang CS, Zell R, Stelzner A: Coexpression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice. Antiviral Res 2004;64:131-136.
7. Chen Z, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, Aizawa C, Kurata T, Tamura S: Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 1999;17:653-659.
8. Webster RG, Fynan EF, Santoro JC, Robinson H: Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 1994;12:1495-1498.
9. Kodihalli S, Haynes JR, Robinson HL, Webster RG: Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J Virol 1997;71:3391-3396.
10. Operschall E, Schuh T, Heinzerling L, Pavlovic J, Moelling K: Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice. J Clin Virol 1999;13:17-27.
11. Operschall E, Pavlovic J, Nawrath M, Molling K: Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene. Intervirology 2000;43:322-330.
12. Henke A, Wagner E, Whitton JL, Zell R, Stelzner A: Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization. J Virol 1998;72:8327-8331.
13. Henke A, Jarasch N, Wutzler P: Vaccination procedures against Coxsackievirus-induced heart disease. Expert Rev Vaccines 2003;2:805-815.
14. Davis HL, Brazolot Millan CL, Mancini M, McCluskie MJ, Hadchouel M, Comanita L, Tiollais P, Whalen RG, Michel ML: DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice. Vaccine 1997;15:849-852.
15. Cho JH, Lee SW, Sung YC: Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization. Vaccine 1999;17:1136-1144.
16. Kusakabe K, Xin KQ, Katoh H, Sumino K, Hagiwara E, Kawamoto S, Okuda K, Miyagi Y, Aoki I, Nishioka K, Klinman D: The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. J Immunol 2000;164:3102-3111.
17. Chow YH, Huang WL, Chi WK, Chu YD, Tao MH: Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 1997;71:169-178.
18. Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB: In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 1997;158:816-826.
19. Xiang ZQ, He Z, Wang Y, Ertl HC: The effect of interferon-gamma on genetic immunization. Vaccine 1997;15:896-898.
20. Lee SW, Cho TH, Sung YC: Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene. J Virol 1998;72:8430-8436.